These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 13825697)

  • 1. The antibody response of roosters to poliomyelitis virus.
    FURESZ J
    J Immunol; 1960 Mar; 84():251-7. PubMed ID: 13825697
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibody response to a vaccination against polio virus during treatment with isonicotinic acid hydrazide].
    PITZURRA M; CUSMA N; BISCATTI O; DONATI M
    Boll Soc Ital Biol Sper; 1962 Feb; 38():130-2. PubMed ID: 14487009
    [No Abstract]   [Full Text] [Related]  

  • 3. Complement-fixing antibody response to inactivated poliovirus vaccine.
    LENNETTE EH; SCHMIDT NJ; MAGOFFINRL
    J Immunol; 1961 Dec; 87():696-706. PubMed ID: 14464005
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of roosters in the antigenicity testing of Salk poliomyelitis vaccine.
    FURESZ J; MOREAU P
    J Immunol; 1963 Feb; 90():192-200. PubMed ID: 13945854
    [No Abstract]   [Full Text] [Related]  

  • 5. Virus excretion and antibody response in clinical and subclinical cases of poliomyelitis.
    BROWN GC
    Ann N Y Acad Sci; 1955 Sep; 61(4):989-95; discussion, 995-7. PubMed ID: 13340607
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of the association between the composition of the serum protein fractions and antibody formation in monkeys immunized with poliomyelitis antigen.
    GHENDON YZ
    J Hyg Epidemiol Microbiol Immunol; 1961; 5():461-9. PubMed ID: 13898183
    [No Abstract]   [Full Text] [Related]  

  • 7. [Viral excretion and antibody formation after use of a live trivalent poliomyelitis vaccine (Cox-Lederle)].
    ENDERS-RUCKLE G; SIEGERT R
    Dtsch Med Wochenschr; 1961 Oct; 86():1999-2008. PubMed ID: 13890174
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on poliomyelitis virus. II. The immunogenic potency of live and inactivated virus in guinea-pigs.
    HAMPTON JW; POLSON A; SELZER G
    J Hyg (Lond); 1958 Jun; 56(2):260-5. PubMed ID: 13563867
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunization of infants with living attenuated poliomyelitis virus; laboratory investigations of alimentary infection and antibody response in infants under six months of age with congenitally acquired antibodies.
    FLACK A; HUMMELER K; HUNT AD; JERVIS GA; KOPROWSKI H; NORTON TW; STOKES J
    J Am Med Assoc; 1956 Dec; 162(14):1281-8. PubMed ID: 13366742
    [No Abstract]   [Full Text] [Related]  

  • 10. Heterotypic antibody responses by rabbits inoculated with poliovirus.
    BARNETT EV; BARON S
    J Immunol; 1961 Nov; 87():582-9. PubMed ID: 13865116
    [No Abstract]   [Full Text] [Related]  

  • 11. Poliovirus antibody response after various vaccination schedules and at different ages.
    MACLEOD DR; ARMSTRONG CW; MOSS GW; POTTER FC; WILSON RJ
    Can Med Assoc J; 1959 Sep; 81(6):443-9. PubMed ID: 14419587
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of guinea pigs in tests for immunogenic capacity of poliomyelitis virus preparations.
    GARD S; WESSLEN T; FAGRAEUS A; SVEDMYR A; OLIN G
    Arch Gesamte Virusforsch; 1956; 6(5):401-11. PubMed ID: 13340710
    [No Abstract]   [Full Text] [Related]  

  • 13. [The immunity in the population of the Saarland after poliomyelitis oral vaccination. 1].
    Esser I
    Offentl Gesundheitswes; 1970 Dec; 32(12):655-60. PubMed ID: 4250371
    [No Abstract]   [Full Text] [Related]  

  • 14. Unpredictability of antibody response of infants to injections of Salk poliomyelitis vaccine.
    CRAMBLETT HG; FOMON SJ
    J Pediatr; 1961 Jun; 58():779-84. PubMed ID: 13696225
    [No Abstract]   [Full Text] [Related]  

  • 15. A precipitin test for acute poliomyelitis and for assessing antibody response to oral poliovaccine.
    SELZER G
    J Hyg (Lond); 1962 Mar; 60(1):69-78. PubMed ID: 13910539
    [No Abstract]   [Full Text] [Related]  

  • 16. [A crowding out effect in the preparation of polyvalent neutralizing antisera in rabbits].
    Henigst W
    Zentralbl Bakteriol Orig; 1964 Jul; 193(3):387-97. PubMed ID: 4284149
    [No Abstract]   [Full Text] [Related]  

  • 17. [The kinetic reaction of serological neutralization of poliomyelitis viruses in cell cultures. II. Application to the study of the antigenicity of antipoliomyelitic vaccines on chicks. (Method of the Pasteur Institute)].
    LEPINE P; ROGER F; SAUTTER V; ROGER A
    Bull World Health Organ; 1960; 22(3-4):273-89. PubMed ID: 14415883
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences in stability of antigen-antibody complexes formed with poliovirus and acute and convalescent phase human sera.
    BRUNNER KT; WARD R
    J Immunol; 1959 Oct; 83():405-10. PubMed ID: 13805346
    [No Abstract]   [Full Text] [Related]  

  • 19. Observations on the complement-fixing antibody response to poliovirus in patients with certain Coxsackie and ECHO virus infections.
    LENNETTE EH; SCHMIDT NJ; MAGOFFIN RL
    J Immunol; 1961 May; 86():552-60. PubMed ID: 13760855
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular immunity of monkeys versus antibody titers following oral inoculation with poliomyelitis virus.
    BACHTOLD JG; GEBHARDT LP; WILCOX WC; BUBEL HC
    J Immunol; 1955 Dec; 75(6):475-7. PubMed ID: 13271772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.